Xarelto now an approved medication for flight

Good news on the medication front: The FAA recently accepted Xarelto as an allowed anticoagulant for use in aviation. Xarelto (rivaroxaban) is a new type of anticoagulation drug that has a much more favorable side effect profile than its pharmaceutical cousin, Pradaxa (dabigatran) that produced disappointing side effects associated with uncontrollable bleeding in some patients who were using it. … to continue reading…

Please login or join AOPA and AOPA Pilot Protection Services now to have access to these exclusive expert resources.

Gary Crump, AOPA’s director of medical certification, is a former operating room technician and emergency medical technician who has been assisting AOPA members for more than 25 years. He’s also a medical expert for AOPA’s Pilot Protection Services and has been flying since 1973.